Neurolief - Shaping the Future of Mental HealthCare
Neurolief is a leader in brain neuromodulation, committed to providing relief for millions suffering from mental health and neurological disorders.
Overview
Neurolief is a neuromodulation company based in Netanya, Israel, that focuses on providing relief for patients with mental health and neurological disorders. The company has developed a non-invasive, multi-channel brain neuromodulation system that targets major neural pathways to influence brain regions related to mood and pain control. Neurolief's technology is FDA and CE approved for the treatment of migraine. Additionally, the company is pursuing regulatory approvals for its system to treat Resistant Major Depression.
Details
- Category
- Medical Equipment Manufacturing
- Headquarters
- Netanya, Israel
- Type
- Privately Held
- Founded
- 2014
- Followers
- 6,301
- Specialties
- Wearable, Technology, Brain Neuromodulation, Neurostimulation, Migraine, Depression, Medical device, and Digital health
- Locations
- 12 Giborei Israel St. Netanya, Israel 4250412, IL
Funding
Total rounds: 6
Last round: Convertible note, Sep 21, 2025
Last round amount: US$ 5.0M